KOL & Stakeholder Mapping

KOL & Stakeholder Mapping

Using our InsightAce KOL Intelligence framework, we build targeted KOL databases that support medical affairs strategy, advisory board formation, and clinical trial recruitment planning across therapy areas and geographies.

Request a Consultation →
190+
Consulting Projects
50+
Domain Analysts
16
Industry Verticals
27+
Countries Covered

Overview

Key opinion leaders shape treatment guidelines, influence formulary decisions, and drive adoption of new therapies. Identifying the right KOLs — and understanding their influence networks — is critical for medical affairs, commercial strategy, and clinical development. InsightAce provides rigorous KOL intelligence that goes beyond publication counts to map real influence.

What We Deliver

KOL identification by therapy area and geography
Influence scoring and tier classification
Publication and clinical trial activity profiling
Advisory board and engagement strategy support
Physician awareness, attitude, and usage (AAU) research
Patient referral pattern and compliance analysis
Conference speaker and panel participation tracking
Digital influence and social media presence assessment

Our Methodology: InsightAce 360°

Every kol & stakeholder mapping engagement follows our InsightAce 360° framework: primary KOL research (15–25 interviews), secondary data triangulation, expert validation, and interactive strategy workshops. Deliverables include executive PowerPoint summaries, analyst-ready Excel workbooks, and dedicated post-delivery analyst hours.

Case Study

Oncology KOL Research for New Indication Expansion

Client: Global leader in oncology therapeutics

InsightAce conducted in-depth discussions with 55 KOLs and 2 industry experts to estimate market potential for an existing cancer drug in a new therapeutic indication. Secondary epidemiology research was combined with primary KOL insights and triangulated to derive patient pool identification across all disease stages and treatment centers.

Result: Client identified actual patient pool for their brand across all stages. Received a dynamic forecasting model for future use and accurate opportunity assessment across all treatment channels and patient segments.

How We Approached This

1
Target Market Landscaping: Awareness levels, diagnosis rates, referral patterns, and treated patient numbers by disease stage
2
Treatment Pattern Analysis: Existing protocols, affordability levels, unmet needs, and survival rates across segments
3
Physician AAU Research: Reaction to client product, potential usage, switching behavior, and price sensitivity
4
Opportunity Assessment: Target patient segments, opportunity estimation, and overall market sizing

Client Feedback

“Thank you so much for the data provided and your professionalism. I am gratified with the custom data and additional information on technology trends, pricing analysis and reimbursement/regulatory information.”

Samia Bensalem
VP Regulatory Affairs, KIFFIK Inc

“Many thanks for the very fast delivery of the report and pleasant collaboration. Very helpful. I recommended your service to our colleagues.”

Beiersdorf AG
Start-up Scouting & Portfolio Management

Ready to Discuss KOL & Stakeholder Mapping?

No obligation • Response within 24 hours • Free initial consultation

Request a Consultation →